TELA Bio, Inc. financial data

Symbol
TELA on Nasdaq
Location
1 Great Valley Parkway, Suite 24, Malvern, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 359 % -31.1%
Quick Ratio 84 % -16.2%
Debt-to-equity 781 % +212%
Return On Equity -556 % -180%
Return On Assets -63.1 % -11.2%
Operating Margin -55.4 % +28.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 39.4M shares +60.8%
Common Stock, Shares, Outstanding 24.7M shares +0.94%
Entity Public Float 245M USD +351%
Common Stock, Value, Issued 25K USD +4.17%
Weighted Average Number of Shares Outstanding, Basic 24.7M shares +0.9%
Weighted Average Number of Shares Outstanding, Diluted 24.7M shares +0.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 68.6M USD +29.3%
Research and Development Expense 9.47M USD -1.98%
Selling and Marketing Expense 67.9M USD +25.3%
General and Administrative Expense 15.2M USD +7.89%
Operating Income (Loss) -38M USD +7.75%
Nonoperating Income (Expense) -3.48M USD -38.4%
Net Income (Loss) Attributable to Parent -41.5M USD +5.1%
Earnings Per Share, Basic -1.66 USD/shares +16.6%
Earnings Per Share, Diluted -1.66 USD/shares +16.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 17.3M USD -70.3%
Inventory, Net 13.6M USD -5.05%
Assets, Current 44.1M USD -46.3%
Property, Plant and Equipment, Net 2.42M USD +38.5%
Operating Lease, Right-of-Use Asset 1.8M USD +63%
Intangible Assets, Net (Excluding Goodwill) 1.83M USD -17.2%
Other Assets, Noncurrent 2.57M USD
Assets 53M USD -39.3%
Accounts Payable, Current 2.48M USD -19.8%
Employee-related Liabilities, Current 7.85M USD +10.8%
Accrued Liabilities, Current 14.4M USD +17.4%
Liabilities, Current 16.9M USD +9.94%
Operating Lease, Liability, Noncurrent 1.7M USD +41.7%
Other Liabilities, Noncurrent 1.46M USD +36.7%
Liabilities 59.3M USD +4.45%
Accumulated Other Comprehensive Income (Loss), Net of Tax 149K USD +10.4%
Retained Earnings (Accumulated Deficit) -350M USD -13.5%
Stockholders' Equity Attributable to Parent -6.27M USD -121%
Liabilities and Equity 53M USD -39.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.4M USD -24.3%
Net Cash Provided by (Used in) Financing Activities 56K USD
Net Cash Provided by (Used in) Investing Activities 4.7M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 24.7M shares +0.94%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.59M USD +19.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 17.6M USD -69.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.18M USD +7.46%
Deferred Tax Assets, Valuation Allowance 71.1M USD +18.2%
Deferred Tax Assets, Gross 72M USD +18.2%
Operating Lease, Liability 2.25M USD +43.2%
Depreciation 139K USD +15.8%
Payments to Acquire Property, Plant, and Equipment 304K USD +164%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -41.5M USD +5.4%
Lessee, Operating Lease, Liability, to be Paid 3.74M USD +83.2%
Property, Plant and Equipment, Gross 6.32M USD +8.54%
Operating Lease, Liability, Current 559K USD +62%
Lessee, Operating Lease, Liability, to be Paid, Year Two 580K USD +58.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 601K USD +67.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.49M USD +218%
Lessee, Operating Lease, Liability, to be Paid, Year Three 557K USD +48.5%
Deferred Tax Assets, Operating Loss Carryforwards 61.4M USD +11.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 570K USD +48.8%
Operating Lease, Payments 400K USD +33.3%
Additional Paid in Capital 343M USD +1.38%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 4.51M USD -6.54%
Interest Expense 5.31M USD +21%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%